News
UNM
52.95
+1.98%
1.03
Dividend Champion, Contender, And Challenger Highlights: Week Of July 14
The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts. In the past week, the following companies declared dividends which changed from their previous payout. These dividend growth stocks have ex-dividend dates approaching. The weekly series highlights recent and upcoming dividend related activity for dividend stocks on the D dividend Champions list.
Seeking Alpha · 2d ago
Unum raises dividend by 15.1%
Unum Group (UNM) declared $0.42/share quarterly dividend, 15.1% increase from prior dividend of $.36. Forward yield 3.23% Payable Aug. 16; for shareholders of record July 26; ex-div July 26.
Seeking Alpha · 3d ago
Press Release: Unum Group Declares Quarterly Dividend of $0.420 Per Share of its Common Stock
Dow Jones · 3d ago
Unum lands Overweight rating from Piper Sandler
Unum lands Overweight rating from Piper Sandler. The life and health insurer "has the greatest growth, least reliance on variable investment income," analyst says. UNM gained 0.5% in late morning trading on Thursday. Piper Sandlers initiated coverage on Unum Group with an overweight rating.
Seeking Alpha · 4d ago
Wells Fargo Remains a Buy on Unum Group (UNM)
TipRanks · 4d ago
Unum Group Price Target Announced at $57.00/Share by Piper Sandler
Dow Jones · 4d ago
Unum Group Initiated at Overweight by Piper Sandler
Dow Jones · 4d ago
Piper Sandler Initiates Coverage On Unum Gr with Overweight Rating, Announces Price Target of $57
Benzinga · 4d ago
Strong Buy Rating for Unum Group: Underwriting Excellence and Strategic HR Partnerships Drive Growth Post-Pandemic
TipRanks · 4d ago
Zacks Industry Outlook Highlights Aflac, Unum Group and Trupanion
NASDAQ · 4d ago
Unum Group Is Maintained at Buy by Jefferies
Dow Jones · 4d ago
Unum Group Price Target Raised to $64.00/Share From $63.00 by Jefferies
Dow Jones · 4d ago
Jefferies Maintains Buy on Unum Gr, Raises Price Target to $64
Benzinga · 4d ago
Morgan Stanley Keeps Their Hold Rating on Unum Group (UNM)
TipRanks · 5d ago
Unum (UNM) to Divest Medical Stop Loss Business to Amynta Group
NASDAQ · 5d ago
Amynta Group To Acquire Unum Group's Medical Stop Loss Business; Terms Not Disclosed
The business will operate as a full-service managing general underwriter under Amynta Risk Solutions. The transaction is expected to close in the third quarter of 2024. The business provides medical stop loss coverage to a diversified group of employers and industries across the U.S.
Benzinga · 6d ago
*Unum Group Expects to Close Sale in 3Q
Dow Jones · 6d ago
*Unum Group Announces Sale of Medical Stop Loss Ops to Amynta Group
Dow Jones · 6d ago
Press Release: Unum Group Announces Sale of Medical Stop Loss Operations to Amynta Group
Dow Jones · 6d ago
Weekly Report: what happened at UNM last week (0701-0705)?
Weekly Report · 07/08 09:13
More
Webull provides a variety of real-time UNM stock news. You can receive the latest news about Unum through multiple platforms. This information may help you make smarter investment decisions.
About UNM
Unum Group is a provider of workplace benefits and services. The Company provides financial protection benefits in the United States and the United Kingdom (UK). Its products include disability, life, accident, critical illness, dental and vision, and other related services. The Company has three segments: Unum US, Unum International, and Colonial Life. Its Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. Its Unum International segment includes its operations in the UK and Poland. Unum UK's business includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and others. Unum Poland's business includes insurance for individual and group life with accident and health riders. Its Colonial Life segment includes accident, sickness, and disability products, life products, and cancer and critical illness products.